Review
Ergolytic drugs in medicine and sports

https://doi.org/10.1016/0002-9343(93)90185-RGet rights and content

Abstract

Just as drugs that enhance exercise capacity and/or athletic performance are often called “ergogenic,” drugs that impair these functions can be termed “ergolytic.” Today's athletes hear too much about the former and too little about the latter. Ergolytic drugs used today by certain athletes include alcohol, marijuana, smokeless tobacco, cocaine, antihypertensives, eye drops, and diuretics. Some antidepressants, too, can be ergolytic, as well as some antihistamines and other common drugs—even caff eine—in some settings, for some people. Internists can help their fitness-minded patients by educating them about ergolytic drugs and by tailoring their management to foster peak performance at work and play.

References (57)

  • WG Squires et al.

    Hemodynamic effects of oral smoke-less tobacco in dogs and young adults

    Prev Med

    (1984)
  • QR Regestein

    Pathologic sleepiness induced by caffeine

    Am J Med

    (1989)
  • JD Cantwell

    The internist as sports medicine physician

    Ann Intern Med

    (1992)
  • TE Graham et al.

    Performance and metabolic responses to a high caffeine dose during prolonged exercise

    J Appl Physiol

    (1991)
  • ER Eichner

    Better dead than second: blood doping, erythropoietin, and athletes

    J Lab Clin Med

    (1992)
  • T Osler et al.

    Ultramarathoning: the next challenge

  • T Noakes
  • RM Lang et al.

    Adverse cardiac effects of alcohol ingestion in young adults

    Ann Intern Med

    (1985)
  • TJ Regan

    Alcohol and the cardiovascular system

    JAMA

    (1990)
  • American College of Sports Medicine

    The use of alcohol in sports

    Med Sci Sports Exerc

    (1982)
  • V Bond et al.

    Alcohol, cardiorespiratory function and work performance

    Br J Sports Med

    (1984)
  • JA Houmard et al.

    Effects of the acute ingestion of small amounts of alcohol on 5-mile run times

    J Sports Med

    (1987)
  • L McNaughton et al.

    Alcohol and its effect on sprint and middle distance running

    Br J Sports Med

    (1986)
  • G Borg et al.

    Effect of alcohol on perceived exertion in relation to heart rate and blood lactate

    Eur J Appl Physiol

    (1990)
  • R Roine et al.

    Aspirin increases blood alcohol concentrations in humans after ingestion of alcohol

    JAMA

    (1990)
  • DP Tashkin
  • KD Bird et al.

    Intercannabinoid and cannabinoid-ethanol interactions and their effects on human performance

    Psychopharmacology (Berl)

    (1980)
  • AM Renaud et al.

    Acute effects of marijuana smoking on maximal exercise performance

    Med Sci Sports Exerc

    (1986)
  • MH Williams

    Alcohol, marijuana, and beta blockers

  • ED Glover et al.

    Implications of smokeless tobacco use among athletes

    Physician Sportsmed

    (1986)
  • WA Anderson et al.

    A national survey of alcohol and drug use by college athletes

    Physician Sportsmed

    (1991)
  • KA Perkins et al.

    Effects of nicotine on perceived exertion during low-intensity activity

    Med Sci Sports Exerc

    (1991)
  • RB Jones

    Prohibit smokeless tobacco use in athletic competition

    Physician Sportsmed

    (1987)
  • SW Edwards et al.

    The effects of smokeless tobacco on heart rate and neuromuscular reactivity in athletes and nonathletes

    Physician Sportsmed

    (1987)
  • RH Strauss

    Spittin' image: breaking the sports-tobacco connection

    Physician Sportsmed

    (1991)
  • R Voy

    Drugs, sport, and politics

  • D Roth et al.

    Acute rhabdomyolysis associated with cocaine intoxication

    N Engl J Med

    (1988)
  • LL Creglar et al.

    Medical complications of cocaine abuse

    N Engl J Med

    (1986)
  • Cited by (33)

    • Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance

      2022, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Therefore, blood THC concentrations may not be indicative of cannabis consumption nor predict impairment, particularly over 5 h post-treatment (Arkell et al., 2020) underlining the urgent need for further exploration into its potential for carry-over impacts on cognition as well as its possible therapeutic benefits (Bonn-Miller et al., 2021). Indeed, lengthened detection and uncertain carry-over effects of THC further implicate careers of athletes due to THC prohibition in professional sports despite its long known ergolytic nature, resulting in much controversy (Campos et al., 2003; Eichner, 1993; Huestis et al., 2011). We acknowledge that the highly heterogenous cannabinoid treatment dosages, treatment periods and administration routes examined likely contributed to inconsistencies in our results.

    • Use of Addictive Medications and Drugs in Athletics

      2010, Principles of Addictions and the Law: Applications in Forensic, Mental Health, and Medical Practice
    • Use of Addictive Medications and Drugs in Athletics

      2010, Principles of Addictions and the Law
    • Recreational drugs

      1998, Clinics in Sports Medicine
    View all citing articles on Scopus
    1

    From the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

    View full text